Shop by Category

CellMosaic® is a platform technology company dedicated to creating high-quality, innovative, and advanced bioconjugates. Bioconjugates are used broadly as research tools, diagnostic reagents, and as a novel modality for drugs, such as antibody-drug conjugates (ADCs). Since its establishment in 2008, CellMosaic® has invested significant research efforts into developing innovative linkers, crosslinking technologies, and advanced conjugation processes. CellMosaic® currently offers bioconjugation-related reagents/kits, customer bioconjugation services, contract bioconjugate development and manufacturing, and partnerships to develop proprietary, innovative AqT® bioconjugates and ADCs.